R.B. Rastogi

1.3k total citations
56 papers, 1.0k citations indexed

About

R.B. Rastogi is a scholar working on Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, R.B. Rastogi has authored 56 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cellular and Molecular Neuroscience, 20 papers in Endocrinology, Diabetes and Metabolism and 19 papers in Molecular Biology. Recurrent topics in R.B. Rastogi's work include Neuroscience and Neuropharmacology Research (25 papers), Thyroid Disorders and Treatments (17 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). R.B. Rastogi is often cited by papers focused on Neuroscience and Neuropharmacology Research (25 papers), Thyroid Disorders and Treatments (17 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). R.B. Rastogi collaborates with scholars based in Canada, United States and South Africa. R.B. Rastogi's co-authors include Radhey L. Singhal, Y.D. Lapierre, Pavel D. Hrdina, Z. Merali, R. A. Agarwal, Prasanta Ghosh, Alexander I. Gray, W. R. Bezwoda, Martin Birkhofer and B. Korecký and has published in prestigious journals such as Brain Research, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

R.B. Rastogi

56 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.B. Rastogi Canada 21 457 254 243 147 118 56 1.0k
P.S. Timiras United States 19 491 1.1× 207 0.8× 370 1.5× 89 0.6× 243 2.1× 63 1.2k
Richard H. Alper United States 23 472 1.0× 195 0.8× 322 1.3× 253 1.7× 182 1.5× 53 1.3k
B. W. L. Brooksbank United Kingdom 22 263 0.6× 232 0.9× 450 1.9× 103 0.7× 187 1.6× 46 1.3k
Wendy A. Pouliot United States 18 496 1.1× 95 0.4× 316 1.3× 76 0.5× 76 0.6× 25 1.0k
A. Leake United Kingdom 20 307 0.7× 125 0.5× 567 2.3× 184 1.3× 365 3.1× 46 1.4k
Nathan M. Appel United States 19 675 1.5× 123 0.5× 460 1.9× 108 0.7× 276 2.3× 35 1.2k
Lindsey Grandison United States 24 963 2.1× 396 1.6× 621 2.6× 334 2.3× 328 2.8× 42 2.0k
M. Ballabio Italy 17 326 0.7× 215 0.8× 171 0.7× 137 0.9× 109 0.9× 33 811
Deborah L. Armstrong United States 18 506 1.1× 81 0.3× 518 2.1× 62 0.4× 140 1.2× 37 1.1k
Ulrich Mußhoff Germany 19 401 0.9× 85 0.3× 539 2.2× 44 0.3× 151 1.3× 37 1.2k

Countries citing papers authored by R.B. Rastogi

Since Specialization
Citations

This map shows the geographic impact of R.B. Rastogi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.B. Rastogi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.B. Rastogi more than expected).

Fields of papers citing papers by R.B. Rastogi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.B. Rastogi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.B. Rastogi. The network helps show where R.B. Rastogi may publish in the future.

Co-authorship network of co-authors of R.B. Rastogi

This figure shows the co-authorship network connecting the top 25 collaborators of R.B. Rastogi. A scholar is included among the top collaborators of R.B. Rastogi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.B. Rastogi. R.B. Rastogi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aamdal, Steinar, U. Bruntsch, Jaap Verweij, et al.. (1997). Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicity. Cancer Chemotherapy and Pharmacology. 40(5). 439–443. 9 indexed citations
2.
Bezwoda, W. R., R.B. Rastogi, A Valla, et al.. (1995). Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate-and high-grade non-Hodgkin's lymphomas. European Journal of Cancer. 31(6). 903–911. 22 indexed citations
3.
Olver, Ian, Michael Green, Guy C. Toner, et al.. (1995). A Phase II Trial of Zeniplatin in Metastatic Melanoma. American Journal of Clinical Oncology. 18(1). 56–58. 8 indexed citations
4.
Bezwoda, W. R. & R.B. Rastogi. (1994). A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up.. PubMed. 31(2 Suppl 3). 3–3. 3 indexed citations
5.
Markman, Maurie, Linda C. DeMarco, Martin Birkhofer, et al.. (1993). Phase II trial of zeniplatin (CL 286 558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy. Journal of Cancer Research and Clinical Oncology. 119(4). 234–236. 5 indexed citations
6.
Willemse, P.H.B., Jourik A. Gietema, Nanno H. Mulder, et al.. (1993). Zeniplatin in patients with advanced ovarian cancer, a phase II study with a third generation platinum complex. European Journal of Cancer. 29(3). 359–362. 8 indexed citations
7.
Gray, Alexander I., et al.. (1987). Triterpenoid Saponins fromCaltha palustris. Planta Medica. 53(1). 98–100. 9 indexed citations
8.
Rastogi, Shiva K., R.B. Rastogi, Radhey L. Singhal, & Y.D. Lapierre. (1983). SL76002 – Effect on Gamma-Aminobutyric Acid and Dopamine in Animals Treated Chronically with Haloperidol. Neuropsychobiology. 9(4). 211–214. 3 indexed citations
9.
Lapierre, Y.D., R.B. Rastogi, & Radhey L. Singhal. (1983). Fluvoxamine Influences Serotonergic System in the Brain: Neurochemical Evidence. Neuropsychobiology. 10(4). 213–216. 17 indexed citations
10.
Singhal, Radhey L. & R.B. Rastogi. (1982). MIF-1: Effects on norepinephrine, dopamine and serotonin metabolism in certain discrete brain regions. Pharmacology Biochemistry and Behavior. 16(2). 229–233. 9 indexed citations
11.
Rastogi, R.B., Radhey L. Singhal, & Y.D. Lapierre. (1980). Thyrotropin releasing hormone: Neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines. Psychopharmacology. 72(1). 85–91. 13 indexed citations
12.
Rastogi, R.B. & Radhey L. Singhal. (1978). The effect of thyroid hormone on serotonergic neurones: Depletion of serotonin in discrete brain areas of developing hypothyroid rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 304(1). 9–13. 12 indexed citations
13.
Rastogi, R.B. & Radhey L. Singhal. (1977). Lithium suppresses elevated behavioural activity and brain catecholamines in developing hyperthyroid rats. Canadian Journal of Physiology and Pharmacology. 55(3). 490–495. 5 indexed citations
14.
Agarwal, R. A., et al.. (1977). Enhancement of Locomotor Activity and Catecholamine and 5-Hydroxytryptamine Metabolism by Thyrotropin Releasing Hormone. Neuroendocrinology. 23(4). 236–247. 35 indexed citations
15.
Agarwal, R. A., Y.D. Lapierre, R.B. Rastogi, & Radhey L. Singhal. (1977). ALTERATIONS IN BRAIN 5‐HYDROXY‐TRYPTAMINE METABOLISM DURING THE ‘WITHDRAWAL’ PHASE AFTER CHRONIC TREATMENT WITH DIAZEPAM AND BROMAZEPAM. British Journal of Pharmacology. 60(1). 3–9. 19 indexed citations
16.
Rastogi, R.B. & Radhey L. Singhal. (1976). Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.. Journal of Pharmacology and Experimental Therapeutics. 198(3). 609–618. 80 indexed citations
17.
Rastogi, R.B., Y.D. Lapierre, & Radhey L. Singhal. (1976). EVIDENCE FOR THE ROLE OF BRAIN BIOGENIC AMINES IN DEPRESSED MOTOR ACTIVITY SEEN IN CHEMICALLY THYROIDECTOMIZED RATS1. Journal of Neurochemistry. 26(3). 443–449. 46 indexed citations
18.
Rastogi, R.B., et al.. (1975). Effect of radio-thyroidectomy and thyroid hormone replacement therapy on cardiac protein kinase activity and ATP hydrolysis.. PubMed. 12(4). 751–64. 1 indexed citations
19.
Rastogi, R.B. & Radhey L. Singhal. (1975). Effect of Chronic Cadmium Treatment on Rat Adrenal Catecholamines. Endocrine Research Communications. 2(1). 87–94. 21 indexed citations
20.
Rastogi, R.B. & Radhey L. Singhal. (1974). Alterations in brain norepinephrine and tyrosine hydroxylase activity during experimental hypothyroidism in rats. Brain Research. 81(2). 253–266. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P.S. Timiras Breakdown of academic impact, for papers by Richard H. Alper Breakdown of academic impact, for papers by B. W. L. Brooksbank Breakdown of academic impact, for papers by Wendy A. Pouliot Breakdown of academic impact, for papers by A. Leake Breakdown of academic impact, for papers by Nathan M. Appel Breakdown of academic impact, for papers by Lindsey Grandison Breakdown of academic impact, for papers by M. Ballabio Breakdown of academic impact, for papers by Deborah L. Armstrong Breakdown of academic impact, for papers by Ulrich Mußhoff
Rankless by CCL
2026